일화디앤아이

비상장계속사업자

ild&i

김재일

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

일화디앤아이

Business Reg. No. 5438601214 · CEO 김재일

I.Investment Overview

Target일화디앤아이 (5438601214)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명일화디앤아이
영문명ild&i
대표자김재일
사업자등록번호5438601214
법인등록번호1801111237915
설립일2019.08.30
종업원수9명

V.Workforce

9

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW3.820214.9202216.4202348202437.42025
영업이익100M KRW1.920212.820222.5202352024-4.72025
순이익100M KRW-0.320210.12022-2.820231.52024-9.42025
Item20252024202320222021
자산총계277.2억원262.5억원181.9억원185.6억원183.9억원
부채총계154.5억원130.5억원124.5억원131.8억원130.3억원
자본총계122.7억원132.1억원57.5억원53.8억원53.7억원
매출액37.4억원48억원16.4억원4.9억원3.8억원
영업이익-4.7억원5억원2.5억원2.8억원1.9억원
순이익-9.4억원1.5억원-2.8억원1,485만원-2,877만원

VII.Financial Ratios

FY2025 basis

-12.43%

영업이익률

-24.99%

순이익률

-3.38%

ROA

-7.62%

ROE

125.89%

부채비율

44.27%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

일화디앤아이 투심보고서 | Alpha Lenz